Fulminant streptococcus infection of soft tissues;Infección estreptocócica fulminante de partes blandas

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 18, Issue 1, 2000, Pages 16-18

  Corredoira, Juan Carlos ^a,b   Toledo, Amadeo ^a   Bermejo, Ricardo ^a   Rodríguez, Asunción ^a   Coira, Amparo ^a  

^a HOSPITAL XERAL CALDE   (Spain)

^b NONE   (Spain)

Author keywords

Necrotizing fascitis; Streptococcic myositis; Streptococcus pyogenes

Indexed keywords

ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; MYOSITIS; NECROTIZING FASCIITIS; SOFT TISSUE INFECTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

DIAGNOSIS, DIFFERENTIAL; FASCIITIS, NECROTIZING; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOSITIS; SOFT TISSUE INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0033629412     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Stevens D. Invasive group A streptococcus infections. Clin Infect Dis 1992; 14: 2-13.
2. McGowan JE, Barnes MW, Findland M. Bacteremia at Boston city Hospital: Ocurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases. J Infect Dis 1975; 132: 316-335.
3. Bartter T, Dascal A, Carroll K, Curley F. «Toxic strep syndrome»: a manifestation of group A streptococcal infection. Arch Intern Med 1988; 88: 1421-1424.
4. Francis J, Warren R. Streptococcus pyogenes bacteraemia in Cambridge -a review of 67 episodes. Q J Med 1988; 68: 603-613.
5. Strömberg A, Romanus V, Burman LG. Outbreak of group A streptococcal bacteremia in Sweden. An epidemiological and clinical study. J Infect Dis 1991; 164: 595-598.
6. Demers B, Simor A, Vellend H, Schlievert P, Byrne S, Jamieson F et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993: 16: 792-800.
7. Stevens D, Tanner M, Winship J, Swarts R, Ries K, Schlievert P et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989: 321: 1-7.
8. Henkel J, Armstrong D, Blevins A, Moody MD. Group A betahemolytic streptococcus bacteremia in a cancer hospital. JAMA 1970; 211: 983-986.
9. Bernaldo de Quirós J, Moreno S, Cercenado E, Díaz D, Berenguer J, Miralles P et al. Group A streptococcal bacteremia. A 10-year prospective study. Medicine (Baltimore) 1997; 76: 238-248.
10. Barg NL, Kish MA, Kauffman CA, Supena RB. Group A streptococcal bacteremia in intravenous drug abusers. Am J Med 1979; 66: 596-602.
11. Ruben FL, Norden CW, Heisler B, Korica Y. An outbreak of Streptococcus pyogenes infections in a nursing home. Ann Intern Med 1984; 101: 494-496.
12. Bisno A, Stevens D. Streptococcal infections of skin and soft tissues. N Engl J Med 1996; 334: 240-245.
13. Strasberg S, Silver M. Hemolytic streptococcus gangrene: an uncommon but frequently fatal infection in the antibiotic era. Am J Surg 1968; 115: 763-768.
14. Yoder E, Mendez J, Khatib R. Spontaneous gangrenous myositis induced by Streptococcus pyogenes: case report and review of the literature. Rev Infect Dis 1987; 9: 382-385.
15. Adams E, Gudmundsson S, Yocum D, Haselby R, Craig W, Sundstrom W. Streptococcal myositis. Arch Intern Med 1985; 145: 1020-1023.
16. Narula A, Khatib R. Characteristic manifestations of Clostridium induced spontaneous gangrenous myositis. Scand J Infect Dis 1985; 17: 291-294.
17. Betriu C, Sánchez A, Gómez M, Cruceyra A, Picazo J. Antibiotic susceptibility of group A streptococci: a 6-year follow-up study. Antimicrob Agents Chemother 1993; 37: 1665-1667.
18. Stevens D, Gibbons A, Bergstrom R, Winn V. The Eagle effect revisited: efficacy of clindamicin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988; 158: 23-28.
19. Pérez D, López A, Aguado J. Fascitis necrosante estreptocócica de evolución fulminante. Med Intensiva 1997; 21: 125-126.